131 related articles for article (PubMed ID: 16077365)
1. Bilateral retinal venous occlusion and unilateral cystoid macular edema in Churg-Strauss syndrome treated with intravitreal triamcinolone.
Chen SD; Lochhead J; Satchi K; Patel CK; Frith P
Retina; 2005; 25(5):655-7. PubMed ID: 16077365
[No Abstract] [Full Text] [Related]
2. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Soto-Pedre E; Hernaez-Ortega MC
Am J Ophthalmol; 2004 Mar; 137(3):596; author reply 596-7. PubMed ID: 15013911
[No Abstract] [Full Text] [Related]
4. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Kwong YY; Lai WW; Lam DS
Am J Ophthalmol; 2004 Mar; 137(3):593-4; author reply 594. PubMed ID: 15013906
[No Abstract] [Full Text] [Related]
5. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
8. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide.
Yepremyan M; Wertz FD; Tivnan T; Eversman L; Marx JL
Ophthalmic Surg Lasers Imaging; 2005; 36(1):30-6. PubMed ID: 15688969
[TBL] [Abstract][Full Text] [Related]
9. Periocular triamcinolone acetonide as treatment for macular edema secondary to branch vein occlusion associated with retinal arteriovenous malformation.
Federici T; Batlle I
Retina; 2006; 26(9):1079-80. PubMed ID: 17151499
[No Abstract] [Full Text] [Related]
10. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
Jonas JB; Kreissig I; Degenring RF
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):782-3. PubMed ID: 12271378
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone.
Stefánsson E
Ophthalmology; 2007 Aug; 114(8):1590; author reply 1590. PubMed ID: 17678704
[No Abstract] [Full Text] [Related]
12. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Park CH; Jaffe GJ; Fekrat S
Am J Ophthalmol; 2003 Sep; 136(3):419-25. PubMed ID: 12967793
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.
Karacorlu M; Karacorlu SA; Ozdemir H; Senturk F
Retina; 2007 Oct; 27(8):1026-30. PubMed ID: 18040239
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide for treatment of cystoid macular edema associated with retinitis pigmentosa.
Kim JE
Retina; 2006; 26(9):1094-6. PubMed ID: 17151506
[No Abstract] [Full Text] [Related]
15. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
Gregori NZ; Rosenfeld PJ; Puliafito CA; Flynn HW; Lee JE; Mavrofrides EC; Smiddy WE; Murray TG; Berrocal AM; Scott IU; Gregori G
Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288
[TBL] [Abstract][Full Text] [Related]
16. Combined radial optic neurotomy, internal limiting membrane peeling, and intravitreal triamcinolone acetonide for central retinal vein occlusion.
Furino C; Ferrari TM; Boscia F; Cardascia N; Sborgia L; Reibaldi M; Ferreri P; Sborgia C
Ophthalmic Surg Lasers Imaging; 2005; 36(5):422-5. PubMed ID: 16238044
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials.
Flynn HW; Scott IU
Arch Ophthalmol; 2005 Feb; 123(2):258-9. PubMed ID: 15710825
[No Abstract] [Full Text] [Related]
18. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Er H
Am J Ophthalmol; 2006 Oct; 142(4):710; author reply 710. PubMed ID: 17011888
[No Abstract] [Full Text] [Related]
20. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
